We analyzed the relationship between tumor‐infiltrating immune cells (CD4, CD8, FOXP3, CD163‐positive cells) and proteins (TGFβ1 and its downstream signal, SMAD3) expression and survival after the start of combined therapy with immune checkpoint inhibitors plus chemotherapy in SCLC. The gene discussed is CD4; the disease is small cell lung carcinoma.